This HTML5 document contains 167 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1093/ANNONC/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q42451161
rdf:type
wikibase:Item
schema:description
১৬ ডিসেম্বর ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ articolo scientifico article scientific 2013年論文 teaduslik artikkel articol științific мақолаи илмӣ научна статия vitskapeleg artikkel 2013년 논문 vědecký článek 2013年論文 bài báo khoa học scientific article published on 16 December 2013 naučni članak scientific article published on 16 December 2013 vitenskapelig artikkel 2013年论文 tudományos cikk artikulong pang-agham videnskabelig artikel artykuł naukowy научни чланак bilimsel makale επιστημονικό άρθρο artículu científicu espublizáu en 2013 2013年论文 article scientifique наукова стаття, опублікована в грудні 2013 vetenskaplig artikel научни чланак artigo científico 2013 nî lūn-bûn 2013年論文 2013年论文 2013年论文 artículo científico publicado en 2013 wissenschaftlicher Artikel научная статья artigo científico wetenschappelijk artikel scientific article published on 16 December 2013 article científic 2013年论文 artikull shkencor artikel ilmiah 2013年論文 บทความทางวิทยาศาสตร์ scienca artikolo vedecký článok tieteellinen artikkeli 2013年论文 מאמר מדעי artigo científico 2013年の論文 სამეცნიერო სტატია مقالة علمية نشرت في 16 ديسمبر 2013 2013年論文
p:P577
wds:Q42451161-1D7FF8D7-DB6D-4C53-B591-D8730A5487BB
wdt:P577
2013-12-16T00:00:00Z
p:P2860
wds:Q42451161-F7201DB3-38C3-4FB6-8965-A5AA76B4A754 wds:Q42451161-E288EAE9-32F9-4B75-8D6C-40E7810E2AD4 wds:Q42451161-CF864EE3-4D13-4F99-8A45-CC2594218666 wds:Q42451161-D72E6841-5DFF-478D-BE73-36C0D0AF5516 wds:Q42451161-B5E67A73-6239-40FF-A52E-BD835ADDA727 wds:Q42451161-B86ECC1C-CC90-44DE-8473-73371CD0C15B wds:Q42451161-C34F76FF-ABCA-4765-9E3C-E0B22CD1C7E9 wds:Q42451161-CB9FD8F4-DFC2-4BB6-A080-E228F3DC85B8 wds:Q42451161-6AF0EBD0-0B6E-4253-AFD6-1CA01FA24F92 wds:Q42451161-67DD6608-B1EA-408A-B166-E69A80329328 wds:Q42451161-28AA9E7A-1D2F-4B22-B5F4-9F878FC79DC2 wds:Q42451161-2BBFC8EB-DB76-41A3-AC29-C0059091D3C5 wds:Q42451161-07C406B7-C582-4ACE-8671-E492E55A5DF1
wdt:P2860
wd:Q34440858 wd:Q28297827 wd:Q34189116 wd:Q35130819 wd:Q29617404 wd:Q34943802 wd:Q29547513 wd:Q34354769 wd:Q35007222 wd:Q39554997 wd:Q34268261 wd:Q54570423 wd:Q24597456
p:P2093
wds:Q42451161-FD09E0D6-181F-4F26-9FC7-D001D69B5BA8 wds:Q42451161-F5CC5D3B-3D5C-49EB-BD89-F06825E6D644 wds:Q42451161-D2F51413-FCC5-4EB0-B178-7589D51E18DF wds:Q42451161-CF615EDC-4E81-49D1-8734-7A2AAA6EE2BF wds:Q42451161-F20DBDE0-D3A3-4539-85BB-B48A4EABD1D2 wds:Q42451161-D97B1F11-5101-467B-B14A-8B21DCC1737E wds:Q42451161-015ECB4F-1B32-42D1-B330-85B2BC607334 wds:Q42451161-03063BEB-EE56-4707-8BED-234AD3DF5D5F wds:Q42451161-159C5A81-9BA2-4A4A-8CB5-37344288B05D wds:Q42451161-0BAF0DB4-4E82-47F1-9B4B-6C0A8F2BB9BF wds:Q42451161-4F83FA3C-88DC-4741-B467-1154F408986F wds:Q42451161-4A83FD1B-52DC-41BA-8940-B0277BADC990 wds:Q42451161-4B3D3A95-4C42-4EBF-A9F5-59387E2C1E5F wds:Q42451161-5C3C76B7-9E24-48DB-8D2F-C296031F166B wds:Q42451161-63D155FE-661C-47C1-8BA5-C4DEB877FC3B wds:Q42451161-1F6DA8E4-83EE-4A00-A7AA-595954202978 wds:Q42451161-3DECF309-1B22-41CE-9881-1683AEE2EE5C wds:Q42451161-AFDE7412-AA3E-4159-8EA4-E00919BD69CF wds:Q42451161-975007BD-7058-4779-AFAB-62A4ACB2FF60 wds:Q42451161-79817984-6F5E-4CAE-9039-CB567DB4A4EB wds:Q42451161-7B25AD26-F9B4-42C5-A6C6-D5BB14479F7F wds:Q42451161-84E01953-5B7D-4DD8-9B4C-ACB91283ED6C
wdt:P2093
R Bartsch S Liu Austrian Breast and Colorectal Cancer Study Group B Mlineritsch C Singer M Filipits S Ressler G Steger H Stoeger P Dubsky M Knauer M Balic S Ferree J Storhoff C Schaper W Kwasny R Greil T O Nielsen C Fesl R Jakesz J W Cowens M Rudas
rdfs:label
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy al Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy al
skos:prefLabel
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy al Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy al
schema:name
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy al Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy al
p:P50
wds:Q42451161-6B6D6470-BDFC-4896-A1D3-7038683BC8F7 wds:Q42451161-895AEE48-0645-43C7-8CA5-566F8F2F9C52 wds:Q42451161-ABFEF2E1-AA93-433D-AA4F-B6E0BEB0987F
wdt:P50
wd:Q18025935 wd:Q91473170 wd:Q73014138
p:P1476
wds:Q42451161-30177883-0984-41AF-AF1A-F0867943E836
wdt:P1476
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
p:P304
wds:Q42451161-801DEC3B-75AD-469C-B9DE-E5BD0C23BA11
wdt:P304
339-345
p:P31
wds:Q42451161-DF68BA09-3CAB-4B9D-8552-028D8548DE98
wdt:P31
wd:Q13442814
p:P921
wds:Q42451161-403123D8-D5EF-4C32-A659-01F36F29C6C6
wdt:P921
wd:Q181600
p:P698
wds:Q42451161-67E94331-EAE3-4A79-B89B-E744D8F2E3E7
wdtn:P698
n12:24347518
wdt:P698
24347518
p:P1433
wds:Q42451161-511DD523-56DE-410F-814C-7EB6FFBCCBF2
wdt:P1433
wd:Q326122
p:P433
wds:Q42451161-7F83A820-FF77-4994-AE24-241859C2414F
p:P478
wds:Q42451161-2F93C91F-0EB1-458D-891F-6E9B89FD8189
wdt:P433
2
wdt:P478
25
p:P356
wds:Q42451161-1F9FFEDC-BE06-4460-91D9-C8B35ECA85FF
wdtn:P356
n9:MDT494
wdt:P356
10.1093/ANNONC/MDT494
p:P8608
wds:Q42451161-FCDE1E07-CBB9-4727-B335-E998401FEA20
wdt:P8608
release_44sxhazlbfai3alomqccyib2sq
p:P5875
wds:Q42451161-ACF576FB-0E56-4A7D-A657-E9B17B3E03F5
wdt:P5875
262045575